QCM
VIR icon

Quantinno Capital Management’s Vir Biotechnology VIR Stock Holding History

Quantinno Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
127,925
+31,998
+33% +$304K ﹤0.01% 2353
2026
Q1 		$860K Buy
95,927
+56,655
+144% +$451K ﹤0.01% 2279
2025
Q4 		$237K Buy
39,272
+16,391
+72% +$97.6K ﹤0.01% 2971
2025
Q3 		$131K Buy
22,881
+44
+0.2% +$225 ﹤0.01% 2855
2025
Q2 		$115K Buy
22,837
+4,129
+22% +$22.1K ﹤0.01% 2483
2025
Q1 		$121K Buy
+18,708
New +$166K ﹤0.01% 1985
2024
Q3 		– Sell
-10,828
Closed -$96.4K – 1496
2024
Q2 		$96.4K Buy
+10,828
New +$104K ﹤0.01% 1297

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quantinno Capital Management's VIR Position: Q2 2026 in Review

Quantinno Capital Management increased its Vir Biotechnology (VIR) stake by 33% in Q2 2026, buying an estimated $304K and bringing the position to 127,925 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Quantinno Capital Management first reported a position in VIR in Q2 2024 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Quantinno Capital Management held 127,925 shares of Vir Biotechnology worth $1.3M as of Q2 2026.
  • Quantinno Capital Management bought 31,998 Vir Biotechnology shares in Q2 2026, an estimated $304K.
  • Vir Biotechnology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2353 holding.
  • Quantinno Capital Management first reported a position in Vir Biotechnology in Q2 2024 and has held it in 7 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.